SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is experiencing a surge in community engagement and social media momentum as supporters rally around the project's 'culture-first' branding and upcoming milestones. Investors are increasingly connecting the token to broader cannabis sector trends and shifting regulatory sentiment, positioning it as a grassroots-driven alternative within the decentralized ecosystem.

Praetorian Acquisition Corp. - Ordinary Shares - Class A

Investors are closely monitoring Praetorian Acquisition Corp. following its recent public debut as the market evaluates the potential for future merger and acquisition activity from the newly formed blank check company.

Blackstone, Inc. engages in the provision of investment and fund management services. It operates through the following segments: Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions. The Real Estate segment includes management of opportunistic real estate funds, Core+ real estate funds, high-yield real estate debt funds, and liquid real estate debt funds. The Private Equity segment consists of management of flagship corporate private equity funds, sector and geographically focused corporate private equity funds, core private equity funds, an opportunistic investment platform, a secondary fund of funds business, infrastructure-focused funds, a life sciences investment platform, a growth equity investment platform, a multi-asset investment program for eligible high net worth investors and a capital markets services business. The Credit and Insurance segment refers to Blackstone Credit, which is organized into two overarching strategies: private credit which includes mezzanine direct lending funds, private placement strategies, stressed and distressed strategies and energy strategies, and liquid credit which consists of CLOs, closed-ended funds, open ended funds and separately managed accounts. In addition, the segment includes an insurer-focused platform, an asset-based finance platform, and publicly traded master limited partnership investment platform. The Hedge Fund Solutions segment focuses on Blackstone Alternative Asset Management, which manages a broad range of commingled and customized hedge fund of fund solutions. It also includes a GP Stakes business and investment platforms that invest directly, as well as investment platforms that seed new hedge fund businesses and create alternative solutions through daily liquidity products. The company was founded by Stephen Allen Schwarzman in 1985 and is headquartered in New York, NY.

Blackstone Inc

Blackstone is trending as investors weigh its aggressive pivot toward private credit and AI-driven infrastructure against lingering concerns regarding industry-wide redemption pressures and valuation risks in the real estate sector. The community is sharply divided, with some betting on a long-term turnaround fueled by record dry powder and strategic deployment, while others are closely monitoring potential liquidity constraints that could signal broader credit cycle risks.

Lemonade, Inc. is a holding company, which engages in the provision of insurance services. The firm's products include renters and homeowners insurance, and pet insurance. It offers insurance coverage under the homeowners multi-peril, inland marine, and general liability lines of business. The company was founded by Daniel Asher Schreiber and Shai Wininger on June 17, 2015 and is headquartered in New York, NY.

Lemonade Inc

Lemonade is currently seeing significant momentum as investors digest its latest quarterly results, which showcased accelerating revenue growth and improved margins that suggest its AI-driven model is gaining traction. The stock remains a focal point for the retail community, who are actively debating its valuation versus its disruptive potential, while some traders continue to monitor for short-squeeze opportunities driven by high short interest and institutional interest.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt is experiencing significant market volatility driven by speculation around potential strategic partnerships and its role in emerging crypto-finance infrastructure. Investors are actively debating the impact of recent dilution, the company'spivot toward stablecoin settlement, and the potential for a short squeeze as the community monitors upcoming investor events.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending due to the announcement that its commercial-grade GP2 vials are approved and actively being used in the FLAMINGO-01 Phase 3 clinical trial, signaling a major operational milestone and de-risking of the supply chain. The community is heavily focused on the elite Steering Committees unprecedented co-authorship of upcoming AACR conference abstracts, with long-term investors interpreting this as a strong vote of confidence in the trials progress toward interim results.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is trending as investors react to the recent appointment of a new CFO and continued speculation regarding a potential hyperscaler tenant for its data center campus. Community discourse remains divided, with supporters highlighting upcoming catalysts and infrastructure scale, while skeptics point to the lack of official contract announcements and concerns over the company's delivery timeline.

Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY.

Morgan Stanley

Morgan Stanley shares are surging following a strong third-quarter earnings report, where significant growth in investment banking fees and record-breaking wealth management results topped analyst expectations. The community is actively discussing the firm's robust trading performance and capitalizing on its strong market positioning as part of a broader rally in the financial sector.

Devon Energy Corp. engages in the exploration, development, and production of oil and natural gas properties. It develops and operates Delaware Basin, Eagle Ford, Heavy Oil, Barnett Shale, STACK, and Rockies Oil. The company was founded by J. Larry Nichols and John W. Nichols in 1971 and is headquartered in Oklahoma City, OK.

Devon Energy Corp.

Devon Energy is generating significant market interest as momentum traders track strengthening price structures and bullish call option activity ahead of upcoming earnings. The community is actively debating the stock's potential for a breakout, driven by ongoing M&A speculation, sector-wide energy demand, and analysts identifying the stock as an undervalued acquisition candidate.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXT Inc. is seeing intense investor focus as the semiconductor material specialist captures attention for its strategic role in the AI-driven photonics and data center infrastructure supply chain. The community is actively debating the company's growth potential amid ongoing geopolitical tensions, with discussions polarized between those focused on the high-demand bottleneck for indium phosphide wafers and others skeptical of the valuation relative to past financial performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>One investor on Stocktwits said that the stock needs a new announcement to go higher.&nbsp;</li><li>Earlier in the month, the company was approved for uplisting to the New York Stock Exchange from the NYSE American.&nbsp;</li><li>The company was also awarded $27 Million by the Department of War (DOW) under Title III of the Defense Production Act to enhance, innovate, and expand domestic extraction.&nbsp;</li></ul>United States Antimony Corp. (UAMY)&nbsp;garnered retail interest on Monday as the ongoing war in Iran, and&nbsp;its recent uplisting to the New York Stock Exchange (NYSE)&nbsp;fueled investor optimism.&nbsp;On Stocktwits, retail sentiment jumped from ‘bullish to ‘extremely bullish’ territory over the past 24 hours.&nbsp;Meanwhile, message volume trended in the ‘high’ territory, with messages jumping 30% in the past day, according to Stocktwits data from Monday morning.&nbsp;<h2 class="st-heading-2">What Are Stocktwits Users Saying?</h2>Retail investors see&nbsp;a 350% upside&nbsp;to UAMY shares&nbsp;as many see the Iran&nbsp;war continuing, which could potentially lead to shortage of ammunition for the U.S.&nbsp;A retail investor on Stocktwits said that they will hold the stock till $50 and further opined that “the U.S. imports roughly 82% of its antimony, with China accounting for roughly 63%. China has previously restricted antimony exports to the U.S.”<stembedurl>https://stocktwits.com/Russiancolusion/message/647665883</stembedurl>Another investor said that the stock needs&nbsp;fresh news to go higher.&nbsp;<stembedurl>https://stocktwits.com/GO_DAWGS/message/647667560</stembedurl>Another user said that buyers remain aggressive on UAMY stock.&nbsp;<stembedurl>https://stocktwits.com/topstockalerts/message/647669921</stembedurl><h2 class="st-heading-2">Uplisting And Military Award</h2>Earlier in the month, the company was approved for uplisting to the New York Stock Exchange from the NYSE American.&nbsp;The uplisting to the NYSE marks a further advancement in the UAMY’s ongoing goal to continue enhancing its institutional and retail shareholder base by providing a new market maker specialist and enhanced trading characteristics on the NYSE.&nbsp;Earlier this month, the company was awarded $27&nbsp;million by the Department of War (DOW) under Title III of the Defense Production Act to enhance, innovate, and expand domestic extraction, processing, and refinement of critical materials.The award was approved last year but was delayed due to a government shutdown. DOW's $27 million investment in UAMY will fund modernization and expand the company's capacity located in Montana to refine and produce antimony necessary for flame retardants, batteries, munitions, and other defense applications, it further added.&nbsp;Shares in the company have risen 108% so far in 2026.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the United States Antimony (US Antimony) logo is seen displayed on a smartphone screen

Why Do Retail Investors Believe UAMY Shares Have A 350% Upside Potential?

United States Antimony Corp. garnered retail interest on Monday as the ongoing war in Iran, and its recent uplisting to the New York Stock Exchange fueled investor optimism. 

Equity

United States Antimony Corp. garnered retail interest on Monday as the ongoing war in Iran, and its recent uplisting to the New York Stock Exchange fueled investor optimism. 


<ul class="summary-bullets"><li>Sable’s onshore pipelines have been shut down for a decade since the 2015 Refugio Beach oil spill.</li><li>California Attorney General Rob Bonta had filed a lawsuit against the Trump Administration in January, challenging the PHMSA orders that “illegally assert” exclusive jurisdiction over two California onshore oil pipelines of Sable offshore.</li></ul>Sable Offshore shares rallied nearly 10% on Friday after White House invoked Defense Production Act aimed at bypassing California state regulations to allow oil production off the state coast in bid to ease global oil supply pressures created due to the ongoing Iran war.&nbsp;“Today’s order will strengthen America’s oil supply and restore a pipeline system vital to our national security and defense, ensuring that West Coast military installations have the reliable energy critical to military readiness”, Energy Secretary Chris Wright reportedly said. It was followed by an executive order by Donald Trump adjusting certain delegations under the U.S. Defense Production Act.&nbsp;Energy Secretary Chris Wright directed Sable Offshore Corp. to begin restoring operations for the Santa Ynez Unit and Santa Ynez Pipeline System in California, Bloomberg News report said.<h2 class="st-heading-2">Sable-California&nbsp;</h2>Sable’s onshore pipelines have been shut down for a decade since the 2015 Refugio Beach oil spill, when a corroded segment of one pipeline ruptured and released hundreds of thousands of gallons of oil near Santa Barbara.California Attorney General Rob Bonta in January had filed a lawsuit against the Trump Administration, challenging the Pipeline and Hazardous Materials Safety Administration’s (PHMSA) orders that “illegally assert” exclusive jurisdiction over two California onshore oil pipelines of Sable offshore which are known as the Las Flores Pipelines or lines CA-324 and CA-325, and allow them to restart operations.&nbsp;<h2 class="st-heading-2">Iran’s War Hitting Oil Supplies</h2>The efforts come at a time when the U.S.-Israel war with Iran has disrupted global supply of oil and other key energy products due to the blockade of Strait of Hormuz by Iran.The International Energy Agency this week announced it will release 400 million barrels of oil from their emergency reserves to help address disruptions in oil markets caused by the war in the Middle East.&nbsp;Retail sentiment around SOC trended in ‘extremely bullish’ territory amid ‘extremely high’ message volume.&nbsp;Shares in SOC have jumped 72% so far in 2026.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Trump Clears Path For Sable To Restart California Operations Amid Ongoing Iran War

 Energy Secretary Chris Wright directed Sable Offshore Corp. to begin restoring operations for the Santa Ynez Unit and Santa Ynez Pipeline System in California, Bloomberg News report said.

<ul class="summary-bullets"><li>The company swung to profit in Q4 and reported earnings per share of $0.05 versus year-ago loss per share of $0.22.</li><li>Adjusted operating expenses for the fourth quarter of 2025 were $6.5 million compared to $11.9 million for the fourth quarter of 2024.</li><li>On Stocktwits, retail sentiment around DMRC&nbsp;stock trended in ‘extremely bullish’ territory amid ‘high’ message volume.&nbsp;</li></ul>DigiMarc (DMRC) shares rallied 7% during extended hours of trading after it reported a&nbsp;higher-than-expected&nbsp;fourth-quarter (Q4) revenue on Wednesday.&nbsp;DMRC’s total revenue for Q4 2025 was $8.9 million compared to $8.7 million for the fourth quarter of 2024. Analysts on average expected $8.2 million in revenue, as per data from&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="http://fiscal.ai">Fiscal.ai</a>.&nbsp;<h2 class="st-heading-2">Q4 Snapshot</h2>DigiMarc’s subscription revenue for Q4 2025 came at $5.3 million compared to $5.0 million for the fourth quarter of 2024. The increase reflects $1.4 million of patent license fees earned during the quarter and higher subscription revenue from new and existing commercial contracts, partially offset by a $1.4 million decrease relating to the expiration of two previously disclosed commercial contracts in 2025,&nbsp;the company said.The company's adjusted net income for Q4 2025 was $1.0 million or $0.05 per diluted share compared to adjusted net loss of $4.6 million or $0.22 per diluted share for the fourth quarter of 2024.“Digimarc is capitalizing on the convergence of key trends driving increased demand for our solutions, positioning ourselves to benefit from - not be the casualty of - the relentless advance of AI," said Riley McCormack, Digimarc CEO. "In Q4 2025, we achieved both positive non-GAAP net income and positive free cash flow. Looking ahead to 2026, we expect to generate significant ARR growth."<h2 class="st-heading-2">Expenses Come Down</h2>Operating expenses for the quarter were $10.0 million, compared to $14.4 million for Q4 2024.&nbsp;The decrease was led by lower cash compensation costs of $4.4 million, largely due to lower headcount, and lower professional services costs of $0.6 million, partially offset by higher stock compensation costs of $0.7 million.&nbsp;Adjusted operating expenses for the quarter were $6.5 million compared to $11.9 million for Q4 2024.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around DMRC&nbsp;stock trended in ‘extremely bullish’ territory amid ‘high’ message volume.&nbsp;Shares in the company have fallen 9.4% so far in 2026.For updates and corrections, email newsroom[at]stocktwits[dot]com.

On Stocktwits, retail sentiment around DMRC stock trended in ‘extremely bullish’ territory amid ‘high’ message volume. 

DigiMarc Stock Rallies After Hours On Q4 Revenue Beat

DMRC’s total revenue for the fourth quarter of 2025 was $8.9 million compared to $8.7 million for the fourth quarter of 2024.

<ul class="summary-bullets"><li>Northland also lowered the firm's price target on Webull to $14 from $18 and kept an ‘Outperform’ rating on the shares.</li><li>Northland cited lower peer multiples for the firm's lowered target.&nbsp;</li><li>The company on Wednesday posted net income per ordinary share of $0.01, below Wall Street estimates of $0.05 per share as per data from Fiscal.ai.</li></ul>Webull shares continued their decline on Thursday, falling more than 6%&nbsp;on the heels of fourth-quarter (Q4) earnings that fell short of analyst expectations. The shares also attracted price target&nbsp;cuts from several analysts.&nbsp;Rosenblatt lowered the firm's price target on Webull to $12 from $15 and kept a ‘Buy’ rating on the shares, per TheFly.Northland also lowered the firm's price target on Webull to $14 from $18 and kept an ‘Outperform’ rating on the shares.&nbsp;<h2 class="st-heading-2">Street Rationale</h2>Rosenblatt said Webull's Q4 results showed a strong top-line beat and record account growth, though elevated marketing spend offset some upside, resulting in over $20 million in adjusted core profit. Progress in crypto, prediction markets, and international initiatives positions the company well for 2026 and supports above-consensus growth expectations, the firm said in a research note.&nbsp;Meanwhile, Northland said that Webull reported "nice growth and higher marketing spend" in Q4, however citing lower peer multiples for the firm's lowered target, as per TheFly.&nbsp;<h2 class="st-heading-2">Q4 Report</h2>Webull posted its Q4 results on Wednesday,&nbsp;reporting a total revenue jump of 50% year-over-year to $165.2 million compared to a street expectation of $161.3 million as per data from Fiscal.ai. It was helped by a 56% rise in trading-related revenue year-over-year,&nbsp;the company said.&nbsp;The company posted net income per ordinary share of $0.01, below Wall Street estimates of $0.05 per share, as per data from Fiscal.ai.Webull launched corporate bond trading for U.S. customers in Q4, building on its previous rollout of U.S. government bond trading, which has enabled further user portfolio diversification. Webull’s customer assets totaled $24.6 billion, an all-time high, representing 81% year-over-year growth, driven by market recovery and strong net deposits, which grew 225% year-over-year.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around BULL stock trended in ‘extremely bullish’ territory amid ‘extremely high’ message volume.Shares in the company have fallen nearly 28% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, a person holds a smartphone displaying the logo of Webull Corporation.

Webull Stock Continues Decline After Q4 Earnings Miss – What Does The Street Think?

Rosenblatt lowered the firm's price target on Webull to $12 from $15 and kept a ‘Buy’ rating on the shares, per TheFly.

<ul class="summary-bullets"><li>The company reported a total revenue jump of 50% year-over-year to $165.2 million.&nbsp;</li><li>This was helped by a 56% rise year-over-year in trading-related revenue.&nbsp;</li><li>Webull’s customer assets totaled $24.6 billion, an all-time high, representing 81% year-over-year growth, driven by market recovery and strong net deposits.&nbsp;</li></ul>Webull shares fell in extended hours of trading on Wednesday after it posted a fourth-quarter (Q4) profit that missed analyst estimates.&nbsp;The company posted net income per ordinary share of $0.01, below Wall Street estimates of $0.05 per share as per data from Fiscal.ai.&nbsp;Adjusted net income decreased to $14.6 million for the quarter, compared to $15.0 million for the prior year comparative quarter.Shares in the company were down 2.3% at the time of writing.&nbsp;<h2 class="st-heading-2">Earnings Snapshot</h2>The company reported a total revenue jump of 50% year-over-year to $165.2 million. It was helped by a 56% rise in trading-related revenue year-over-year.Webull launched corporate bond trading for U.S. customers in Q4, building on its previous rollout of U.S. government bond trading, which has enabled further user portfolio diversification.It also entered into a partnership with Meritz Financial Group to offer South Korean investors access to U.S. equity markets.&nbsp;"We reported another quarter of strong financial performance, particularly in our equities and options businesses, which contributed to a significant full-year revenue increase," said H.C. Wang, Chief Financial Officer of Webull. "We're seeing robust returns on our strategic investment in marketing, innovation and addressable market expansion and are confident that we are positioning Webull to deliver lasting shareholder value."<h2 class="st-heading-2">Customer Assets At All-Time High</h2>Webull’s customer assets totaled $24.6 billion, an all-time high, representing 81% year-over-year growth, driven by market recovery and strong net deposits, which grew 225% year-over-year.&nbsp;Its registered users increased 15% year-over-year to 26.8 million users and funded accounts increased to 5.0 million, representing 8% year-over-year growth.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around BULL stock trended in ‘extremely bullish’&nbsp;territory amid ‘extremely high’ message volume.&nbsp;One bullish user praised the earnings and called the stock undervalued.&nbsp;<stembedurl>https://stocktwits.com/Prepthebull/message/646619291</stembedurl>Shares in the company have fallen nearly 25% year-to-date.&nbsp;

In this photo illustration, the Webull Corporation logo is seen displayed on a smartphone screen. 

Webull Stock Falls As Q4 Profit Miss Disappoints Traders

The company posted net income per ordinary share of $0.01 that was below Wall Street estimates of $0.05 per share as per data from Fiscal.ai. 

<ul class="summary-bullets"><li>U.S. President Donald Trump on Monday said that while the U.S. has projected a timeline of four to five weeks for the Iran mission, the country has the capability to extend it far longer.&nbsp;</li><li>In other news, Red Cat on Monday announced that Allen Control Systems (ACS), has joined the Red Cat Futures Initiative.</li><li>ACS will collaborate with Red Cat to evaluate integration opportunities between its Bullfrog autonomous counter-drone system and Red Cat’s secure ISR platforms.&nbsp;</li></ul>Red Cat Holdings stock&nbsp;caught investors’ attention on Monday after the U.S. and Israel launched coordinated strikes on Iran over the weekend,&nbsp;boosting demand for defense stocks.&nbsp;Red Cat Holding&nbsp;Red Cat Holdings Inc. (<a href="https://stocktwits.com/symbol/RCAT">RCAT</a>) stock surged nearly 17% at the time of writing.&nbsp;<h2 class="st-heading-2">Spike In Defense Stocks</h2>The U.S. and Israel’s attack on Iran&nbsp;over the weekend,&nbsp;and retaliatory strikes by Iran in the&nbsp;Gulf region has put defense-related stocks in focus, with several rallying&nbsp;in anticipation that the war&nbsp;is expected to last weeks.&nbsp;U.S. President Donald Trump on Monday said that while the U.S. has projected a timeline of four to five weeks for the Iran mission, the country has the capability to extend it far longer.&nbsp;Red Cat is a drone technology company that integrates robotic hardware and software for military, government, and commercial operations.<h2 class="st-heading-2">Other News</h2>Red Cat on Monday announced that Allen Control Systems (ACS), has joined the Red Cat Futures Initiative, the company’s industry-wide consortium accelerating advanced autonomous systems for modern warfare.ACS will collaborate with Red Cat to evaluate integration opportunities between its Bullfrog autonomous counter-drone system and Red Cat’s secure (Intelligence, surveillance, and reconnaissance) ISR platforms, and command and control architecture.“U.S. and allied nations are seeking cost-effective and scalable counter-drone systems to provide a new layer of protection on the move and at the edge,” said Mike Wior, co-founder and CEO of ACS.&nbsp;“Partnering with Red Cat and joining the Futures Initiative allows us to integrate our fully autonomous precision weapons station into a proven unmanned platform, advancing these systems beyond basic requirements and enabling them to execute more advanced and complex missions for U.S. military forces and their allies,” Wior added.&nbsp;&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around RCAT&nbsp;shares trended in&nbsp;the ‘extremely bullish’ territory amid ‘extremely high’ message volume.&nbsp;One bullish user said that predicted $20 as the price target for the current week.&nbsp;<stembedurl>https://stocktwits.com/JMJTrading/message/646341982</stembedurl>Shares in the company have jumped 117% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Red Cat Holdings logo is seen displayed on a smartphone screen. 

Red Cat Stock Surges On US-Israel-Iran War

The U.S. and Israel’s attack on Iran over the weekend, and retaliatory strikes by Iran in the Gulf region has put defense-related stocks in focus, with several rallying in anticipation that the war is expected to last weeks. 

<ul class="summary-bullets"><li>Aurinia stated that the revenue from the sales of LUPKYNIS for the treatment of active lupus nephritis rose 29% YoY in Q4 to $74.2 million and 25% YoY for the full year to $271 million.</li><li>LUPKYNIS is the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis, the company said.</li><li>Overall, LUPKYNIS sales accounted for about 96% of the company’s total revenue in Q4 and for the full year 2025.</li></ul>Aurinia Pharmaceuticals Inc. (AUPH) shares gained nearly 4% in Thursday’s pre-market trade after the company posted a fourth-quarter (Q4) earnings and revenue beat.Aurinia reported adjusted earnings per share (EPS) of $1.53 on revenue of $77.1 million, while Wall Street analysts expected an adjusted EPS of $0.22 on revenue of $74.7 million, according to Koyfin data.However, the company’s 2026 revenue guidance fell short of Wall Street expectations. Aurinia guided for revenue in the range of $315 million and $325 million during the year, but the consensus estimate stood at $326.8 million.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/AUPH">Aurinia Pharmaceuticals</a> trended in the ‘bullish’ territory, with message volumes at ‘high’ levels. The stock was among the top three trending tickers on the platform at the time of writing.<h2 class="st-heading-2">Active Lupus Nephritis Therapy Sales Gain Momentum</h2>Aurinia stated that the revenue from the sales of LUPKYNIS for the treatment of active lupus nephritis rose 29% YoY in Q4 to $74.2 million. For the full year, LUPKYNIS sales stood at $271 million, rising 25% YoY.LUPKYNIS is the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis, the company said.Overall, LUPKYNIS sales contributed to about 96% of the company’s total revenue in Q4 as well as the full year 2025.Aurinia also stated that the full-year revenue includes a $10 million milestone payment received by the company following the approval of LUPKYNIS by regulators in Japan.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>One user called Aurinia’s earnings and cash position “solid.”<stembedurl>https://stocktwits.com/VSTN/message/645950955</stembedurl>Another user called Aurinia’s numbers “excellent,” saying they’re excited for the company's long-term shareholders.<stembedurl>https://stocktwits.com/Ballerdad1/message/645950749</stembedurl><a href="https://stocktwits.com/symbol/AUPH">AUPH stock</a> is down 10% year-to-date, but up 80% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/celh-stock-soaring-today-celsius-q4-earnings-beat/cZTG9gDRIb8">CELH Stock Is Soaring Pre-Market Today — What Is Driving The Surge?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Aurinia Pharmaceuticals logo is seen displayed on a smartphone screen

AUPH Stock Gains On Aurinia Pharma’s Q4 Beat, But 2026 Guidance Misses Estimates

Aurinia reported adjusted earnings per share of $1.53 on revenue of $77.1 million, while Wall Street analysts expected an adjusted EPS of $0.22 on revenue of $74.7 million, according to Koyfin data.

<ul class="summary-bullets"><li>Evommune stated that it designed the Phase 2a trial to evaluate the safety and efficacy of an intravenous 5 milligram per kilogram dose of EVO301 over 12 weeks.</li><li>The company said it had 70 patients in the trial, and EVO301 achieved a 33% placebo-adjusted improvement in the Eczema Area and Severity Index at week 12.</li><li>Evommune said EVO301 showed a favorable safety profile with no serious adverse events reported.</li></ul>Evommune Inc. (EVMN) shares nearly doubled in value in Tuesday’s pre-market trade before paring some of the gains to hover 50% higher in the opening trade after the company reported positive results from its atopic dermatitis trial.Evommune stated that its atopic dermatitis treatment, EVO301, met its primary endpoint at week 12 during the&nbsp;mid-stage trial. The company said that EVO301 achieved highly statistically significant outcomes in adult patients with moderate-to-severe atopic dermatitis.Retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/EVMN">Evommune</a> trended in the ‘neutral’ territory at the time of writing. The EVMN stock was among the top five trending tickers on the platform.<h2 class="st-heading-2">Evommune Details Results Of The Trial</h2>Evommune stated that it designed the Phase 2a trial to evaluate the safety and efficacy of an intravenous 5 milligram per kilogram dose of EVO301 over 12 weeks.“These data support our plans to move EVO301 into a Phase 2b dose-ranging trial where we can optimize the dose and seek to further improve patient outcomes,” said Evommune President and CEO, Luis Peña.The company said it had 70 patients in the trial, and EVO301 achieved a 33% placebo-adjusted improvement in the Eczema Area and Severity Index (EASI) at week 12.Evommune said EVO301 showed a favorable safety profile, with no serious adverse events reported and no treatment-related discontinuations due to adverse events.Dr. Mark G. Lebwohl, Dean for Clinical Therapeutics and Chairman Emeritus of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai, stated that EVO301’s ability to target the interleukin-18 (IL-18) mechanism and demonstrate clinically relevant activity could present patients with “real benefits.”<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>One bullish user stated that there has been “only good news” with the Evommune stock so far.<stembedurl>https://stocktwits.com/swingingg/message/644564885</stembedurl>Another user stated that the IL-18, a known inflammatory pathway which plays a key role in various immune processes, is “working great” for dermatitis.<stembedurl>https://stocktwits.com/JanetBSmellin/message/644548490</stembedurl><a href="https://stocktwits.com/symbol/EVMN">EVMN stock</a> is up 45% year-to-date and 44% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/michael-saylor-bitcoin-volatility-bug-as-well-as-feature/cZbUI8AR4Yx">Michael Saylor Calls Bitcoin Volatility Both A Bug And A Feature, Touts It As ‘Digital Capital’: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

This Biotech Stock Nearly Doubled In Value Today Morning – What’s Driving Investor Optimism?

The company said that EVO301 achieved highly statistically significant outcomes in adult patients with moderate-to-severe atopic dermatitis.

Should Vanguard Russell 2000 ETF (VTWO) Be on Your Investing Radar?

<ul class="summary-bullets"><li>The first product on the list is Hydrelix, a Type 1 collagen powder that provides the bioactive components of collagen at the wound site.</li><li>The second product is NovaForm Wound Matrix, a bioglass- and collagen-based wound dressing intended for the management of partial- and full-thickness wounds.</li><li>Summit will also distribute G4Derm Plus, a flowable peptide matrix engineered for rapid, protected wound closure.</li></ul>MiMedx Group Inc. (MDXG) shares gained around 5% in Wednesday morning’s trade after the company entered into an exclusive distribution agreement with Summit Products Group for three of its 510(k) cleared products.According to the agreement, Summit will distribute Hydrelix, NovaForm, and G4Derm Plus, designed to complement MiMedx’s portfolio of leading surgical and wound products.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/MDXG">MiMedx</a> was in the ‘bullish’ territory, with message volumes at ‘extremely high’ levels.<h2 class="st-heading-2">What Will Summit Distribute?</h2>The three products included in the agreement are intended to care for and enhance the closure of wounds.The first product in the list is Hydrelix, which is a Type 1 collagen powder that allows the bioactive components of collagen to be readily available at the wound site, facilitating a more direct and efficient therapeutic effect.The second product is NovaForm Wound Matrix, which is a bioglass and collagen-based wound dressing intended for use in the management of partial and full-thickness wounds. NovaForm can be used for pressure ulcers, venous ulcers, diabetic ulcers, and surgical wounds.&nbsp;The company says NovaForm is designed to maintain a moist environment that supports the body’s natural healing process while protecting the wound.Lastly, Summit will also distribute G4Derm Plus, a flowable peptide matrix engineered for rapid, protected wound closure, spurring tissue regrowth, and controlling bioburden. The company stated that G4Derm Plus mimics the human extracellular matrix (ECM) and acts as a barrier against bacteria.“These are innovative xenograft and synthetic products that strengthen our ability to serve the Surgical &amp; Wound markets,” said MiMedx’s Chief Commercial Officer, Kim Moller.<h2 class="st-heading-2">What Does MiMedx Do?</h2>MiMedx is a Marietta, Georgia-based company with a portfolio of surgical and wound care products designed to help clinicians manage chronic and other hard-to-heal wounds.In December 2025, the company entered into an exclusive agreement with Regen Lab USA LLC to distribute the latter’s RegenKit-Wound Gel in the U.S.<a href="https://stocktwits.com/symbol/MDXG">MDXG stock</a> is down 24% year-to-date and 40% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/amazon-openai-in-talks-to-customize-ai-models/cZbjTCvR4Zu">Amazon, OpenAI In Talks To Customize AI Models To Power E-commerce Giant's Products Such As Alexa: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

MDXG Stock Rises As MiMedx Enters Into Exclusive Distribution Agreement For Three Products

According to the agreement, Summit Products Group will distribute Hydrelix, NovaForm, and G4Derm Plus, designed to complement MiMedx’s portfolio of leading surgical and wound products.

VTWO
Vanguard Russell 2000 ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest VTWO News

VTWOVanguard Russell 2000 ETF